Cabinet of Ministers of Ukraine has adopted the Resolution № 597 from August 12, 2015 «On Amendments Introduction into Cabinet of Ministers of Ukraine Resolution №376 from May 26, 2005», which adjusts the current Resolution of Cabinet of Ministers №376 from 26.05.2005 «On Approval of State Registration (Re-registration) Procedures for Medical Products and their Registration (Re-registration) Duty Amount».
The relative amendments foresee that state registration of medical products procured through specialized international organizations should be conducted on the basis of a claim letter and a conclusion of State Enterprise «State Center for Drug Evaluation and Research of Ministry of Health of Ukraine» made according to the expert studies of registration materials regarding their authenticity.
Together with the state registration claim letter there should be provided the following:
The designated reason for rejection of state registration of the medical product which falls under procurement through international organizations is the failure to submit the abovementioned materials or submission of the low volume package of materials, revelation of unreliable or incomplete information within the submitted documents, recognition of the translation of the medical product package labeling or the instruction of its application to be not authentic.
The decision on registration of such products the Ministry of Health of Ukraine shall make during the period of 7 working days. The validity of registration certificates may last up to March 31, 2019. State registration duty for the specified products shall not be accounted.
The event focused on the transformation of Ukraine's intellectual property sector on its path toward European integration.
Improving access to safe and affordable medicines for the Ukrainian population is one of the Government of Ukraine's top priorities. SAFEMed Activity (2017-2025) has supported this effort by appIying health system strengthening best practices.
The Ministry of Health website has posted a notice about the release of a revised draft order of the Ministry of Health ‘On Approval of Amendments to Certain Re
On 25 September, a webinar was held on the topic: ‘180 days of new drug price regulation. Results, prospects and practical advice.’ The event was organized by LA Law Firm in partnership with Proxima Research International.